fluorometholone has been researched along with Metastase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finney, GG; Gaertner, RA; Lewison, EF; Montague, AC | 1 |
| Goldenberg, IS | 1 |
2 trial(s) available for fluorometholone and Metastase
| Article | Year |
|---|---|
Combined hormone therapy in advanced breast cancer. Triple-blind study of 68 patients treated with dromostanolone and fluorometholone.
Topics: Aged; Androstanols; Breast Neoplasms; Clinical Trials as Topic; Drug Synergism; Female; Fluorometholone; Humans; Middle Aged; Neoplasm Metastasis; Placebos | 1968 |
Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorometholone; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prognosis; Testolactone | 1969 |